Aspermont EV/Sales
What is the EV/Sales of Aspermont?
The EV/Sales of Aspermont Limited is 2.35
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Communication Services sector on ASX compared to Aspermont
What does Aspermont do?
Aspermont Limited provides media services to resource industries in Australia, Asia, Europe, the United States, and internationally. It also provides publications, researches, and events, as well as other publications in partnership with external agencies across various trade sectors, including mining, investment, agriculture, and energy. In addition, the company offers online publications that provide news and information directly on desktops, tablets, and smart phones, as well as print publications through tablet and mobile apps. Further, it organizes events and conferences. Aspermont Limited was incorporated in 1961 and is based in Perth, Australia.
Companies with ev/sales similar to Aspermont
- Biodesix Inc has EV/Sales of 2.35
- Peeks Social has EV/Sales of 2.35
- American Express has EV/Sales of 2.35
- Kelt Exploration has EV/Sales of 2.35
- National Steel and Agro Industries has EV/Sales of 2.35
- Raminfo has EV/Sales of 2.35
- Aspermont has EV/Sales of 2.35
- Kraft Heinz Co has EV/Sales of 2.35
- Datametrex AI has EV/Sales of 2.35
- Fusion Antibodies plc has EV/Sales of 2.35
- Solara Active Pharma Sciences has EV/Sales of 2.35
- Kaman has EV/Sales of 2.35
- GlaxoSmithKline Plc has EV/Sales of 2.35